All In Biotech

Drug Trial Radar · NCT01132040

Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions

An Open Label, Balanced. Randomized, Two-treatment, Two-period, Two-sequence, Single Dose,Crossover, Bioequivalence Study of Primidone 50 mg Tablets of Comparing With That of Mysoline® 50 mg Tablets Under Fasting Conditions.

Last checked: Nov 19, 2026Latest source record: May 27, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

Aug 2006

Primary completion

Sep 2006

Study completion Sep 2006

Sponsor

Sponsor type
Industry
First posted
May 27, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the bioavailability of Primidone 50 mg tablets of Dr.Reddy's comparing with that of Mysoline@ tablets of Yamanouchi Pharma Technologies Inc, in healthy, adult, human subjects under fasting conditions.

Conditions

  • Healthy

Interventions

  • PrimidoneDrug

    Primidone Tablets, USP 50 mg of Dr. Reddy's Laboratories Limited

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Bioequivalence based on Cmax and AUC parametersTime frame: 2 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bioserve Clinical Research Pvt. Ltd,

    HYD, Andhra Pradesh, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.